Cargando…

A Review of the External Validity of Clinical Trials with Beta-Blockers in Heart Failure

BACKGROUND: Beta-blockers (BBs) are the mainstay prognostic medication for all stages of chronic heart failure (CHF). There are many classes of BBs, each of which has varying levels of evidence to support its efficacy in CHF. However, most CHF patients have one or more comorbid conditions such as di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iyngkaran, Pupalan, Toukhsati, Samia R., Thomas, Merlin C., Jelinek, Michael V., Hare, David L., Horowitz, John D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Libertas Academica 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5063839/ https://www.ncbi.nlm.nih.gov/pubmed/27773994 http://dx.doi.org/10.4137/CMC.S38444

Ejemplares similares

Common Comorbidities that Alter Heart Failure Prognosis - Shaping New Thinking for Practice
por: Iyngkaran, Pupalan, et al.
Publicado: (2021)

Forensic interrogation of diabetic endothelitis in cardiovascular diseases and clinical translation in heart failure
por: Thomas, Merlin C, et al.
Publicado: (2020)

Heart Failure Paradigms in the Developed World - A Reflection - Part 1
por: Iyngkaran, Pupalan, et al.
Publicado: (2021)

Self Managing Heart Failure in Remote Australia - Translating Concepts into Clinical Practice
por: Iyngkaran, Pupalan, et al.
Publicado: (2016)

Perspectives On Optimizing Chronic Heart Failure Care Beyond Randomised Controlled Trials – What do we Consolidate and how do we Plan for the Future?
por: Iyngkaran, Pupalan, et al.
Publicado: (2019)

Optimizing Chronic Heart Failure Care Beyond Randomised Controlled Trials – What are the problem areas and potential solutions?
por: Iyngkaran, Pupalan
Publicado: (2016)

Part 1: The Wider Considerations in Translating Heart Failure Guidelines
por: Iyngkaran, Pupalan, et al.
Publicado: (2021)

Contextualizing Genetics for Regional Heart Failure Care
por: Iyngkaran, Pupalan, et al.
Publicado: (2016)

Phase 4 Studies in Heart Failure - What is Done and What is Needed?
por: Iyngkaran, Pupalan, et al.
Publicado: (2016)

Cardiac Imaging in Heart Failure with Comorbidities
por: Wong, Chiew, et al.
Publicado: (2017)

Heart Failure in Minority Populations - Impediments to Optimal Treatment in Australian Aborigines
por: Iyngkaran, Pupalan, et al.
Publicado: (2016)

Chronic Heart Failure and Comorbid Renal Dysfunction - A Focus on Type 2 Cardiorenal Syndrome
por: Preeti, Jois, et al.
Publicado: (2016)

Heart Failure Paradigms in the Developed World – A ‘Taproot’ Plan (Part 2)
por: Iyngkaran, Pupalan, et al.
Publicado: (2022)

Shortness of breath in clinical practice: A case for left atrial function and exercise stress testing for a comprehensive diastolic heart failure workup
por: Iyngkaran, Pupalan, et al.
Publicado: (2017)

Towards Optimal Heart Failure Care: Couples-Oriented Strategies to Improve Patient Adherence and Health Outcomes
por: Toukhsati, Samia R., et al.
Publicado: (2016)

Moving From Heart Failure Guidelines to Clinical Practice: Gaps Contributing to Readmissions in Patients With Multiple Comorbidities and Older Age
por: Iyngkaran, Pupalan, et al.
Publicado: (2018)

Risk stratification for coronary artery disease in multi-ethnic populations: Are there broader considerations for cost efficiency?
por: Iyngkaran, Pupalan, et al.
Publicado: (2019)

Comparison of short and long forms of the Flinders program of chronic disease SELF-management for participants starting SGLT-2 inhibitors for congestive heart failure (SELFMAN-HF): protocol for a prospective, observational study
por: Iyngkaran, Pupalan, et al.
Publicado: (2023)

Defining Vulnerable Patients with Heart Failure: Opportunistic Lessons from Covid-19
por: Satici, Sakine, et al.
Publicado: (2022)

A Review of Randomized Controlled Trials Utilizing Telemedicine for Improving Heart Failure Readmission: Can a Realist Approach Bridge the Translational Divide?
por: Gonzalez Garcia, Manuel, et al.
Publicado: (2019)

Perspective on ‘Phase V’ or Logistics and Regression as Logical Progression for Community Heart Failure Triage
por: Azad, Atro, et al.
Publicado: (2022)

Beta-Blockers and Oxidative Stress in Patients with Heart Failure
por: Nakamura, Kazufumi, et al.
Publicado: (2011)

New advances in beta-blocker therapy in heart failure
por: Barrese, Vincenzo, et al.
Publicado: (2013)

Self-Care Interventions That Reduce Hospital Readmissions in Patients With Heart Failure; Towards the Identification of Change Agents
por: Toukhsati, SR, et al.
Publicado: (2019)

Northern Territory Heart Failure Initiative–Clinical Audit (NTHFI–CA)–a prospective database on the quality of care and outcomes for acute decompensated heart failure admission in the Northern Territory: study design and rationale
por: Iyngkaran, Pupalan, et al.
Publicado: (2014)

The effect of beta-blockers in acute heart failure according to heart rate
por: Kim, Hyun-Jin, et al.
Publicado: (2021)

Poor tolerance of beta-blockers by elderly patients with heart failure
por: Yanagisawa, Satoshi, et al.
Publicado: (2010)

Beta Blockers in Heart Failure: More Evidence for an Old Friend
por: Baek, Sang Hong
Publicado: (2018)

Treatment optimization of beta-blockers in chronic heart failure therapy
por: Niriayo, Yirga Legesse, et al.
Publicado: (2020)

Leukocyte Redistribution: Effects of Beta Blockers in Patients with Chronic Heart Failure
por: von Haehling, Stephan, et al.
Publicado: (2009)

Beta-blocker therapy in elderly patients with renal dysfunction and heart failure
por: Martínez-Milla, Juan, et al.
Publicado: (2021)

Effects of Holding Beta-Blockers on the Vital Signs of Heart Failure Patients
por: Erickson, Marc, et al.
Publicado: (2021)

Beta-blockers and mechanical dyssynchrony in heart failure assessed by radionuclide ventriculography
por: Jones, K. A., et al.
Publicado: (2022)

Beta blocker use in subjects with type 2 diabetes mellitus and systolic heart failure does not worsen glycaemic control
por: Wai, Bryan, et al.
Publicado: (2012)

Bedside–to-Bench Translational Research for Chronic Heart Failure: Creating an Agenda for Clients Who Do Not Meet Trial Enrollment Criteria
por: Iyngkaran, P, et al.
Publicado: (2015)

The Impact of Treatment with Beta-Blockers upon Mortality in Chronic Heart Failure Patients
por: Taneva, Borjanka, et al.
Publicado: (2016)

Beta-blocker Therapy at Discharge in Patients with Acute Heart Failure and Atrial Fibrillation
por: Ahn, Min-Soo, et al.
Publicado: (2020)

Beta-blocker treatment in heart failure patients with atrial fibrillation: challenges and perspectives
por: Chourdakis, Emmanouil, et al.
Publicado: (2021)

Using machine learning to uncover heterogeneity of beta blocker response in heart failure
por: Tison, Geoffrey H.
Publicado: (2022)

Effectiveness and safety of four different beta‐blockers in patients with chronic heart failure
por: Liu, Baoshan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gsqpt62ev2ufkc72paj39bk84p